EUCTR2009-012968-13-GB进行中（未招募）1 期
A Proof of Principle, Double-Blind, Randomised Placebo-Controlled,Multi-centre Trial of pravaStatin to Ameliorate Early Onset Pre-eclampsia - StAmP
niversity College London0 个研究点目标入组 62 人开始时间: 2010年11月30日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •In order to be randomised into the StAmP trial, all eligibility criteria must be satisfied. Investigators will be asked to confirm each eligibility criteria at randomisation.
- •Inclusion Criteria:
- •To be eligible for the StAmP Trial, the women must:
- •1. Aged above 16 years
- •2. Be between 24+0 weeks’ and 31+6 weeks’ gestation
- •3. Have a singleton pregnancy
- •4. Have a diagnosis of early onset Pre-eclampsia (according to definition below)
- •5. Be considered capable of safely continuing the pregnancy for 48 hours or more, as determined by the attending clinician
- •6. Obstetrician and neonatologist believe the fetus is likely to be viable
- •7. No major anomalies evident on the 20-week anomaly scan. Any anomaly should be assessed by the Principal Investigator and discussed with the Chief Investigator, following classification of the anomaly according to the ICD10 codes. All major anomalies will be excluded, but minor anomalies, subject to agreement between the PI and CI will be included
- •8. Be capable of understanding the information provided, with use of an interpreter if required
- •9. Give written informed consent
- •Definition of Pre-eclampsia (24-31+6 weeks gestation)
- •The minimum clinical criteria required to establish a diagnosis of pre-eclampsia are the first two criteria below. The third criterion is relevant if there is chronic hypertension, preceding pregnancy. The other criteria (4-6) are often present in early pre-eclampsia, but are not essential for diagnosis for pre-eclampsia.
- •1. New onset hypertension after 20 weeks gestation defined as diastolic BP greater than 90 mmHg, using Korotkoff sound 5 to define the diastolic level.
- •2. New onset proteinuria 2+ or more on standard urinary dipstick tests confirmed by proteinuria PCR ratio of greater than 30mg/mmol on spot urine test or >300mg/24 hours on a 24 hour urine collection.
- •3. Women who have chronic hypertension, the appearance of new onset proteinuria, (defined above), a sudden increase of blood pressure, thrombocytopenia (platelets <100), elevated transaminases, or a sudden increase in proteinuria in those who have pre-existing proteinuria.
- •4. Liver transaminases may be increased
- •5. Serum creatinine (SCr) may be increased
- •6. Platelet count may be decreased
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 0
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Any women, who at the point of randomisation, exhibit any of the following are not eligible for the trial:
- •1. Eclampsia
- •2. Current use of statins
- •3. Contraindications to statin use (other than pregnancy) including:
- •- Hypersensitivity to pravastatin or any of its excipients
- •- Active liver disease or elevation of serum transaminases not thought to be related to pre-eclampsia
- •- Pre-pregnant renal insufficiency (creatine clearance <30ml/min)
- •- Concomitant administration of potent CYP3A4 inhibitors
- •4. Imminent transfer to a non-trial centre due to unavailability of neonatal cots.
- •5. Participation in any other blinded, placebo-controlled trials of investigational medicinal products in pregnancy.
- •6. Significant uncertainty regarding gestational age. Under 24 weeks' gestation, pregnancies are often not considered viable and therefore women with pre-eclampsia less than 24 weeks gestation will be excluded. Women with pre-eclampsia around 32 weeks’ gestation are often delivered when the mother is stable and therefore we will exclude women who develop pre-eclampsia over 32 weeks’ gestation. For this reason, if there is any uncertainty about the gestational age, the mother should not be approached for randomisation.
- •7. Women who are HIV or hepatitis B positive
研究者
相似试验
进行中（未招募）
1 期
A Proof of Principle, Double-Blind, Randomised Placebo-Controlled,Multi-centre Trial of pravaStatin to Ameliorate Early Onset Pre-eclampsia - StAmPPre-eclampsiaEUCTR2010-023502-12-GBniversity College London
已完成
4 期
Statins to Ameliorate early onset Pre-eclampsiaPregnancy and ChildbirthGestational [pregnancy-induced] hypertension with significant proteinuriaPre-eclampsiaISRCTN23410175niversity College London Hospitals NHS Foundation Trust (UK)62
进行中（未招募）
1 期
Comparison of Vonoprazan to Esomeprazole in Subjects with Symptomatic GERD Who Responded Partially to a High Dose of PPIEUCTR2015-001154-14-CZTakeda Development Centre Europe Ltd213
进行中（未招募）
1 期
Comparison of Vonoprazan to Esomeprazole in Subjects with Symptomatic GERD Who Responded Partially to a High Dose of PPIGastro-Esophageal Reflux DiseaseMedDRA version: 19.0Level: PTClassification code 10017885Term: Gastrooesophageal reflux diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2015-001154-14-BETakeda Development Centre Europe Ltd213
进行中（未招募）
1 期
Comparison of Vonoprazan to Esomeprazole in Subjects with Symptomatic GERD Who Responded Partially to a High Dose of PPIGastro-Esophageal Reflux DiseaseMedDRA version: 19.0 Level: PT Classification code 10017885 Term: Gastrooesophageal reflux disease System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2015-001154-14-GBTakeda Development Centre Europe Ltd256